Completion of Balstilimab BLA Filing Extended To 1H2021

NEXT STORY
Global Microbiome Market Report 2020: Post COVID-19 – The Market is Expected to Decline in the Short-term but Reach $217.22 Million in 2023 at a CAGR of 75.63%
PREV STORY
TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021

author_avatar
NASDAQ Market News

Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

author_avatar
NASDAQ Market News